Vertex Pharmaceuticals (VRTX) EPS & PE Ratio History

Current and historical earning per share (EPS) and price to earnings (PE) ratio for Vertex Pharmaceuticals (VRTX) over the last 10 years. The current PE ratio for Vertex Pharmaceuticals as of April 20, 2018 is 200.19.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $40.309B $2.489B
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.